Research Topics
| G AusSummaryAffiliation: Sahlgrenska University Hospital Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Radical prostatectomy--long-term oncological outcome from a community hospitalMaria Tol-Fakkar
Section of Urology, Ryhov County Hospital, , Sweden
Scand J Urol Nephrol 37:376-81. 2003..CONCLUSIONS: The oncological outcome seems comparable to that reported in the literature, even when the operation is performed in a low-volume community-based setting...
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, SwedenAndrew J Vickers
Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, East 63rd Street, New York, NY 10021, USA
BMC Med 6:19. 2008..We set out to determine whether a multivariable model including four kallikrein forms (total, free, and intact PSA, and human kallikrein 2 (hK2)) could predict prostate biopsy outcome in previously unscreened men with elevated total PSA...- Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohortGunnar Aus
Department of Urology, Sahlgrens University Hospital, 413 45, Goteborg, Sweden
Eur Urol 43:627-31. 2003..It is difficult to give prognostic information based on the present literature. The aim of this study was to evaluate the impact of known risk factors in patients with pelvic node involvement and without distant metastasis... - Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)Gunnar Aus
Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
Scand J Urol Nephrol 37:466-70. 2003..To evaluate whether the free-to-total prostate-specific antigen (F/T-PSA) ratio can be used to differentiate between stage pT2 and pT3 prostate cancer... - Prostate biopsy and anaesthesia: an overviewGunnar Aus
Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
Scand J Urol Nephrol 39:124-9. 2005..To evaluate the efficacy of different methods for decreasing pain and discomfort in men undergoing transrectal ultrasound-guided prostate biopsies and to propose a clinical standard useful for pain relief... - Survival in prostate carcinoma--outcomes from a prospective, population-based cohort of 8887 men with up to 15 years of follow-up: results from three countries in the population-based National Prostate Cancer Registry of SwedenGunnar Aus
Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
Cancer 103:943-51. 2005..To decide on screening strategies and curative treatments for prostate carcinoma, it is necessary to determine the incidence and survival in a population that is not screened... - Individualized screening interval for prostate cancer based on prostate-specific antigen level: results of a prospective, randomized, population-based studyGunnar Aus
Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
Arch Intern Med 165:1857-61. 2005.... - Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer--results from a prospective, population-based randomized controlled trialGunnar Aus
Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
Eur Urol 51:659-64. 2007..The aim of the present report is to evaluate whether PSA-based screening reduces the risk of being diagnosed with metastatic prostate cancer... - Current status of HIFU and cryotherapy in prostate cancer--a reviewGunnar Aus
Department of Urology, Sahlgrens University Hospital, SE 413 45 Goteborg, Sweden
Eur Urol 50:927-34; discussion 934. 2006..To evaluate the current status of high-intensity focused ultrasound (HIFU) and cryosurgery as the primary treatment option in patients with prostate cancer... - Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trialG Aus
Department of Urology, Ryhov Hospital, Jonkoping, Sweden
BJU Int 90:561-6. 2002..e. provide greater potential to completely excise the tumour)... - Cryosurgical ablation of the prostate: 5-year follow-up of a prospective studyGunnar Aus
Department of Urology, Sahlgrenska University Hospital, S 41345, Goteborg, Sweden
Eur Urol 42:133-8. 2002..To study the complications and oncological outcome after cryosurgical ablation of the prostate (CSAP)... - Editorial comment on: Additional surgical intervention after radical prostatectomy, radiation therapy, androgen-deprivation therapy, or watchful waitingGunnar Aus
Department of Urology, Sahlgrens University Hospital, , Sweden
Eur Urol 52:1043. 2007 
The European Association of Urology (EAU) guidelines methodology: a critical evaluationGunnar Aus
Department of Urology, Sahlgrens University Hospital, Goteborg, Sweden
Eur Urol 56:859-64. 2009..Guidelines can be produced and written in numerous ways. The aim of the present article is to describe and evaluate the method currently used to produce the European Association of Urology (EAU) guidelines...- Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratioGunnar Aus
Department of Urology, Sahlgrens University Hospital, S41345 Göteborg, Sweden
Eur Urol 45:160-5. 2004..To evaluate the cumulative risk of having a prostate cancer diagnosis in a repeated screening situation in relation to the free-to-total prostate specific antigen ratio (F/T-PSA)... - Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatmentG Ahlgren
Department of Urology, Lund University, University Hospital, Malmo, Sweden
Prostate 42:274-9. 2000..We studied the extent of neuroendocrine (NE) tumor cell differentiation and its relation to regressive changes in prostate cancer after 3-month hormonal treatment... - Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling orderG Aus
Section of Urology, Ryhov Hospital, Jonkoping, Sweden
Eur Urol 39:655-60; discussion 661. 2001..The aim of this study was to evaluate the cancer detection rate of six systemic prostate biopsies with mid lobar biopsies taken far laterally in the prostate... - Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in SwedenJ Hugosson
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
BJU Int 92:39-43. 2003.... - Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screeningBjörn Zackrisson
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Eur Urol 43:327-32. 2003..To study the follow-up of men with elevated prostate-specific antigen (PSA) (>3 ng/ml) after one benign set of sextant biopsies. From the Göteborg branch of the European Randomised Study of Screening for Prostate Cancer (ERSPC)... - Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendeesAnna Grenabo Bergdahl
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Cancer 115:5672-9. 2009..Who dies from prostate cancer despite participation in a population-based prostate-specific antigen (PSA) screening program?.. - PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancerDavid Robinson
Department of Urology, Ryhov County Hospital, Jonkoping, Sweden
Urology 72:903-7. 2008..To assess the value of prostate-specific antigen (PSA) kinetics in predicting survival and relate this to the baseline variables in men with metastatic hormone-refractory prostate cancer (HRPC)... - Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson
Department of Urology, Sahlgrenska University Hospital, Bruna stråket 11 B, SE 413 45 Goteborg, Sweden
Eur J Cancer 43:2109-16. 2007..0001) and with increasing age (p=0.0016). Anxiety associated with prostate cancer screening in general is low to moderate, even in men with elevated PSA, and severe anxiety affects a smaller group of susceptible men... - Post-radical prostatectomy inguinal hernia: a simple surgical intervention can substantially reduce the incidence--results from a prospective randomized trialJohan Stranne
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
J Urol 184:984-9. 2010..After radical retropubic prostatectomy a postoperative inguinal hernia develops in 15% to 20% of patients. We investigated whether a simple prophylactic procedure during radical retropubic prostatectomy would reduce this incidence... - PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden sectionAli Khatami
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
Int J Cancer 120:170-4. 2007..In younger men with a PSADT of less than 4 years, surveillance does not seem to be a justified alternative, and patient should be informed about the risk with such an approach... - Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinomaJonas Hugosson
Department of Urology, Sahlrenska University Hospital, Gothenburg, Sweden
Cancer 100:1397-405. 2004..The purpose of the current study was to evaluate the effectiveness of a prostate carcinoma screening program in which serum prostate-specific antigen (PSA) levels were measured... - Single-dose orally administered quinolone appears to be sufficient antibiotic prophylaxis for radical retropubic prostatectomyJohan Stranne
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
Scand J Urol Nephrol 38:143-7. 2004..To evaluate a new prophylaxis routine, which was introduced at our clinic in December 1998, comprising a single oral dose of antibiotic given prior to radical retropubic prostatectomy (RRP)... - Mortality results from the Göteborg randomised population-based prostate-cancer screening trialJonas Hugosson
Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden
Lancet Oncol 11:725-32. 2010..One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate... - The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionableBjørn Zackrisson
Departments of Urology and Pathology, Sahlgrenska University Hospital, Goteborg, Sweden
J Urol 171:1500-3. 2004..We evaluated the significance of focal prostate cancer found in sextant biopsies in men participating in a biennial prostate specific antigen (PSA) based screening program... - Prostate cancerJan Erik Damber
Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
Lancet 371:1710-21. 2008.... - Selective urological evaluation in men with febrile urinary tract infectionP Ulleryd
Department of Infectious Diseases, Sahlgrenska University Hospital, Goteborg, Sweden
BJU Int 88:15-20. 2001..To investigate the prevalence and clinical importance of urological abnormalities in men with community-acquired febrile urinary tract infection (UTI)... - EAU guidelines on prostate cancerG Aus
Department of Urology, Ryhov Hospital, Jonkoping, Sweden
Eur Urol 40:97-101. 2001..To develop clinical guidelines for the management of patients with prostate cancer... - Treatment of patients with clinical T3 prostate cancerG Aus
Department of Urology, Ryhov Hospital, Jonkoping, Sweden
Scand J Urol Nephrol 36:28-33. 2002..To describe and evaluate treatment alternatives for patients with clinical T3 prostate cancer... - Evolution of free, complexed, and total serum prostate-specific antigen and their ratios during 1 year of follow-up of men with febrile urinary tract infectionBjörn Zackrisson
Department of Urology, Sahlgrenska University Hospital, Goteborg, Sweden
Urology 62:278-81. 2003..To determine the serum values of free, complexed, and total prostate-specific antigen (PSA) and their ratios in men with febrile urinary tract infection (UTI) during 1 year of follow-up... - Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curableJonas Hugosson
Department of Urology, Sahlgrenska Universitetssjukhuset, , Sweden
J Urol 169:1720-3. 2003..Men with a PSA of 2 to 3 ng./ml. or a value of greater than 3 ng./ml. with negative biopsy may be better served by a shorter screening interval. Thus, different screening intervals are implied depending on baseline PSA... - [Brachytherapy with palladium-103--a new way to deliver radiation therapy for localized prostatic cancer]G Aus
Dept of Urology, Lanssjukhuset Ryhov, Jonkoping, Sweden
Lakartidningen 97:3470-4. 2000..The procedure, indications, contraindications, side effects and results from the literature 28 patients have been treated so far with acceptable proximate side effects and reductions in serum-PSA as expected... - Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factorsDavid Robinson
Section of Urology, Ryhov County Hospital, Jonkoping, Sweden
Scand J Urol Nephrol 41:103-9. 2007..To evaluate the disease-specific mortality of conservatively managed incidental carcinoma of the prostate (T1a and T1b) in relation to prognostic factors... - Erectile function outcome reporting after clinically localized prostate cancer treatmentArthur L Burnett
The Johns Hopkins Hospital, 600 North Wolfe St, Marburg 407, Baltimore, Maryland 21287 2411, USA
J Urol 178:597-601. 2007.... - Guideline for the management of clinically localized prostate cancer: 2007 updateIan Thompson
American Urological Association Education and Research, Inc
J Urol 177:2106-31. 2007 - Second-line therapy after radical prostatectomy failure: for whom? When? How?Gunnar Aus
Eur Urol 51:1155-7; discussion 1157-8. 2007 - Cryosurgery for prostate cancerGunnar Aus
J Urol 180:1882-3. 2008 - Men's perception of fatigue when newly diagnosed with localized prostate cancerAnnikki Jonsson
Department of Primary Care, Höglandssjukhuset, Nassjo, Sweden
Scand J Urol Nephrol 41:20-5. 2007.... - Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reMichael S Cookson
Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
J Urol 177:540-5. 2007.... - Relative importance of sources of symptom-induced distress in urinary bladder cancer survivorsLars Henningsohn
Department of Oncology, Radiumhemmet, Z:6, Karolinska Institute, Box 4402, S-102 68, Stockholm, Sweden
Eur Urol 43:651-62. 2003..It is possible that patient care and clinical research can be made more effective by focusing on important sources of symptom-induced distress... - EAU guidelines on prostate cancerAxel Heidenreich
Department of Urology, University Hospital Cologne, Cologne, Germany
Eur Urol 53:68-80. 2008..To present a summary of the 2007 version of the European Association of Urology (EAU) guidelines on prostate cancer (PCa)...